Compounds > atazanavir sulfate
Page last updated: 2024-09-04

atazanavir sulfate and Co-infection

atazanavir sulfate has been researched along with Co-infection in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's14 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barreiro, P; Fernández-Montero, JV; Labarga, P; Soriano, V; Vispo, E1
Bertz, R; Bifano, M; Grasela, D; Hartstra, J; Hwang, C; Kandoussi, H; Oosterhuis, B; Sevinsky, H; Tiessen, R; Velinova-Donga, M1
Avihingsanon, A; Burger, D; Lewin, SR; Matthews, G; Punyawudho, B; Ruxrungtham, K; Thammajaruk, N; Thongpeang, P1
Cattaneo, D; Clementi, E; Gervasoni, C; Milazzo, L; Riva, A1
Antinori, A; Bigoloni, A; Borderi, M; Caramatti, G; Castagna, A; D'Arminio Monforte, A; Di Biagio, A; Di Giambenedetto, S; Galli, L; Gibellini, D; Guaraldi, G; Lazzarin, A; Montella, F; Rusconi, S; Spagnuolo, V1
Barber, X; Gutiérrez, F; Lidón, F; Masiá, M; Padilla, S; Sanchis, M; Terol, G1
Cavadas, C; Costa, S; do Céu Sousa, M; Machado, M1
Ambrose, P; Benson, CA; Devaraj, C; Ezhilarasi, C; Jenks, JD; Kumarasamy, N; Poongulali, S; Yepthomi, T1
Bani-Sadr, F; Gantner, P; Garraffo, R; Jovelin, T; Pugliese, P; Rey, D; Roger, PM; Treger, M1
Antinori, A; Borghetti, A; Castagna, A; Cauda, R; Chinello, P; Ciccarelli, N; Colafigli, M; D'Ettorre, G; De Luca, A; Di Giambenedetto, S; Di Pietro, M; Fabbiani, M; Focà, E; Francisci, D; Grima, P; Latini, A; Madeddu, G; Mondi, A; Orofino, G; Quiros Roldan, E; Rusconi, S1
Casari, S; Castelli, F; Festa, E; Izzo, I; Lanza, P; Odolini, S; Vavassori, A; Zaltron, S1
Alvarez, E; Cuenca, L; González-Lahoz, J; Morello, J; Rodríguez-Nóvoa, S; Soriano, V; Vispo, E1
Cenderello, G; Di Biagio, A; Loregian, A; Pagni, S; Palù, G; Rosso, R; Sormani, MP; Viscoli, C1
Caruz, A; Girón-Gonzalez, JA; Lopez-Cortes, LF; Marquez, M; Merino, D; Mira, JA; Pineda, JA; Rivero, A; Rivero-Juarez, A; Santos-Gil, I; Tellez, F1

Trials

3 trial(s) available for atazanavir sulfate and Co-infection

ArticleYear
Assessment of pharmacokinetic interactions of the HCV NS5A replication complex inhibitor daclatasvir with antiretroviral agents: ritonavir-boosted atazanavir, efavirenz and tenofovir.
    Antiviral therapy, 2013, Volume: 18, Issue:7

    Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; Carbamates; Coinfection; Cyclopropanes; Drug Interactions; Female; Hepatitis C; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Oligopeptides; Organophosphonates; Pyridines; Pyrrolidines; Ritonavir; Tenofovir; Valine; Viral Nonstructural Proteins; Young Adult

2013
Atazanavir/ritonavir monotherapy: 96 week efficacy, safety and bone mineral density from the MODAt randomized trial.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:6

    Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Bone Density; Coinfection; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Prospective Studies; Ritonavir; RNA, Viral; Treatment Failure; Treatment Outcome; Viral Load

2016
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).
    The Journal of antimicrobial chemotherapy, 2017, 04-01, Volume: 72, Issue:4

    Topics: Adult; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Coinfection; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Ritonavir; RNA, Viral; Viral Load; Young Adult

2017

Other Studies

11 other study(ies) available for atazanavir sulfate and Co-infection

ArticleYear
Low risk of liver toxicity using the most recently approved antiretroviral agents but still increased in HIV-hepatitis C virus coinfected patients.
    AIDS (London, England), 2013, Apr-24, Volume: 27, Issue:7

    Topics: Alkynes; Anti-HIV Agents; Atazanavir Sulfate; Benzoxazines; CD4 Lymphocyte Count; Chemical and Drug Induced Liver Injury; Coinfection; Cyclopropanes; Darunavir; Female; Follow-Up Studies; Hepatitis C; HIV Infections; Humans; Liver; Male; Nevirapine; Oligopeptides; Pyridines; Pyrrolidinones; Raltegravir Potassium; Ritonavir; Sulfonamides

2013
Population pharmacokinetics of tenofovir in HIV/HBV co-infected patients.
    International journal of clinical pharmacology and therapeutics, 2015, Volume: 53, Issue:11

    Topics: Anti-HIV Agents; Atazanavir Sulfate; Coinfection; Cross-Sectional Studies; Drug Interactions; Drug Therapy, Combination; Hepatitis B, Chronic; HIV Infections; HIV Protease Inhibitors; Humans; Kidney; Models, Biological; Nonlinear Dynamics; Renal Elimination; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Thailand; Treatment Outcome

2015
Severe Hyperbilirubinemia in an HIV-HCV-Coinfected Patient Starting the 3D Regimen That Resolved After TDM-Guided Atazanavir Dose Reduction.
    Therapeutic drug monitoring, 2016, Volume: 38, Issue:3

    Topics: 2-Naphthylamine; Anilides; Antiviral Agents; Atazanavir Sulfate; Carbamates; Coinfection; Cyclopropanes; Dose-Response Relationship, Drug; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Lactams, Macrocyclic; Macrocyclic Compounds; Middle Aged; Proline; Ritonavir; Sulfonamides; Uracil; Valine

2016
Comparative Impact of Suppressive Antiretroviral Regimens on the CD4/CD8 T-Cell Ratio: A Cohort Study.
    Medicine, 2016, Volume: 95, Issue:11

    Topics: Adult; Age Factors; Alkynes; Atazanavir Sulfate; Benzoxazines; CD4-CD8 Ratio; Coinfection; Cyclopropanes; Drug Therapy, Combination; Female; Hepatitis C; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Interferon Type I; Male; Middle Aged; Oligopeptides; Raltegravir Potassium; Reverse Transcriptase Inhibitors; Ribavirin; Ritonavir

2016
Antileishmanial activity of antiretroviral drugs combined with miltefosine.
    Parasitology research, 2016, Volume: 115, Issue:10

    Topics: Alkynes; Animals; Anti-Retroviral Agents; Antiprotozoal Agents; Atazanavir Sulfate; Benzoxazines; Coinfection; Cyclopropanes; Darunavir; Delavirdine; Drug Therapy, Combination; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Macrophages; Male; Mice, Inbred BALB C; Nevirapine; Phosphorylcholine; Protease Inhibitors; Reverse Transcriptase Inhibitors; Tenofovir

2016
Improved tuberculosis outcomes with daily vs. intermittent rifabutin in HIV-TB coinfected patients in India.
    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2016, Volume: 20, Issue:9

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Antibiotics, Antitubercular; Atazanavir Sulfate; Child; Child, Preschool; Coinfection; Dose-Response Relationship, Drug; Electronic Health Records; Female; HIV Infections; Humans; India; Infant; Male; Middle Aged; Retrospective Studies; Rifabutin; Ritonavir; Treatment Outcome; Tuberculosis; Young Adult

2016
Switch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical Practice.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Coinfection; Drug Resistance, Viral; Drug Substitution; Female; Genotype; HIV Infections; HIV-1; Humans; Male; Middle Aged; Retreatment; Retrospective Studies; Ritonavir; Time-to-Treatment; Treatment Outcome; Viral Load

2016
[Biliary and kidney lithiasis during treatment with daclatasvir/sofosbuvir/ribavirin and atazanavir/ritonavir + abacavir/lamivudine in an HIV/HCV genotype 4-infected patient: a case report.]
    Recenti progressi in medicina, 2017, Volume: 108, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiviral Agents; Atazanavir Sulfate; Biliary Tract Diseases; Carbamates; Coinfection; Dideoxynucleosides; Drug Combinations; Drug Interactions; Genotype; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Kidney Calculi; Lamivudine; Lithiasis; Male; Pyrrolidines; Ribavirin; Ritonavir; Sofosbuvir; Valine

2017
Short communication: use of serum bilirubin levels as surrogate marker of early virological response to atazanavir-based antiretroviral therapy.
    AIDS research and human retroviruses, 2011, Volume: 27, Issue:10

    Topics: Adult; Alleles; Atazanavir Sulfate; Bilirubin; Biomarkers; CD4 Lymphocyte Count; Coinfection; Female; Follow-Up Studies; Glucuronosyltransferase; Hepatitis C; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Odds Ratio; Oligopeptides; Pyridines; Regression Analysis; Retrospective Studies; RNA, Viral; ROC Curve; Viral Load

2011
Effects of hepatitis C virus infection on the pharmacokinetics of ritonavir-boosted atazanavir in HIV-1-infected patients.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2012, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Cohort Studies; Coinfection; Drug Interactions; Drug Monitoring; Female; Hepatitis C; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Oligopeptides; Pyridines; Ritonavir; Viral Load

2012
Short communication: atazanavir-based therapy is associated with higher hepatitis C viral load in HIV type 1-infected subjects with untreated hepatitis C.
    AIDS research and human retroviruses, 2013, Volume: 29, Issue:2

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Coinfection; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; HIV Infections; Humans; Interferons; Interleukins; Male; Middle Aged; Oligopeptides; Pyridines; RNA, Viral; Viral Load

2013